nach oben

Pediatric Surgery International

Erschienen in:

14.09.2018 | Review Article

Advances in understanding the association between Down syndrome and Hirschsprung disease (DS–HSCR)

verfasst von: S. W. Moore

Erschienen in: Pediatric Surgery International | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

The clinical association between Trisomy 21 (Down syndrome) and aganglionosis (Hirschsprung disease; DS–HSCR) is well-established, being of the order of 5% and remains the most common congenital association with Hirschsprung disease. However, little consensus exists as to the possible etiologic and genetic factors influencing this association. Recent research has identified a number of levels at which development of the enteric nervous system is potentially affected in Trisomy 21. These include a decreased central pool of available neuroblasts for migration into the enteric nervous system, abnormal neuroblast type, poor synaptic nerve function and early germline gene-related influences on the migrating neuroblasts due to genetic mutations of a number of important developmental genes, and possible somatic mutations resulting from alterations in the local tissue microenvironment. In this paper, we review available evidence for this association. In addition, we provide evidence of both germline and somatic gene mutations suggesting causation. Although the picture is complex, recent associations between specific RET proto-oncogene variations have been shown to be significant in Down syndrome patients with Hirschsprung disease, as they probably interfere with vital RET functions in the development of the autonomic and enteric nervous systems, increasing the risk of disturbed normal function. In addition, we explore potential role of other facilitatory influence of other susceptibility genes as well as potential other chromosome 21 gene actions and the microenvironment on the Down syndrome gastro-intestinal tract. The various ways in which trisomy of chromosome influences the enteric nervous system are becoming clearer. The sum of these effects influences the outcome of surgery in Down syndrome patients with Hirschsprung Disease.

World Health Association (2018) WHO’s Human Genomics in Global Health initiative- Downs syndrome. http://www.who.int/genomics/public/geneticdiseases/en/index1.html

Buchin PJ, Levy JS, Schullinger JN (1986) Down’s syndrome and the gastrointestinal tract. J Clin Gastroenterol 8:111–114CrossRef

Levy J (1991) The gastrointestinal tract in Down syndrome. Prog Clin Biol Res 373:245–256PubMed

Spahis JK, Wilson GN (1999) Down syndrome: perinatal complications and counseling experiences in 216 patients. Am J Med Genet 89:96–99CrossRef

Kallen B, Mastroiacovo P, Robert E (1996) Major congenital malformations in Down syndrome. Am J Med Genet 65:160–166CrossRef

Wallace RA (2007) Clinical audit of gastrointestinal conditions occurring among adults with Down syndrome attending a specialist clinic. J Intellect Dev Disabil 32:45–50CrossRef

Weir K, McMahon S, Barry L, Ware R, Masters IB, Chang AB (2007) Oropharyngeal aspiration and pneumonia in children. Pediatr Pulmonol 42:1024–1031CrossRef

Carrascosa-Romero MC, Fernandez-Cordoba MS, Gonzalvez-Pinera J, Gutierrez-Junquera C, Pardal-Fernandez JM (2007) Neurocristopathies: a high incidence of cerebral dysgenesis in patients with Hirschsprung’s disease. Rev Neurol 45:707–712PubMed

Moore SW (2011) Hirschsprung’s disease and the brain. Pediatr Surg Int 27:347–352CrossRef

10.

Passarge E (1967) The genetics of Hirschsprungs disease. N Engl J Med 276:138–143CrossRef

11.

Garver K, Law J, Garver B (1985) Hirschsprung disease: a genetic study. Clin Genet 28:503–508CrossRef

12.

Ikeda K, Goto S (1986) Additional anomalies in Hirschsprungs disease: an analysis based on a nationwide survey in Japan. Z Kinderchir 41:279–281PubMed

13.

Spouge D, Baird PA (1985) Hirschsprungs Disease in a large birth cohort. Teratology 32:171–177CrossRef

14.

Badner JA, Sieber WK, Garver KL, Chakravarti A (1990) A genetic study of Hirschsprung disease. Am J Hum Genet 46:568–580PubMedPubMedCentral

15.

Arnold S, Pelet A, Amiel J, Borrego S, Hofstra R, Tam P, Ceccherini I, Lyonnet S, Sherman S, Chakravarti A (2009) Interaction between a chromosome 10 RET enhancer and chromosome 21 in the Down syndrome-Hirschsprung disease association. Hum Mutat 30:771–775CrossRef

16.

Moore SW, Zaahl MG (2012) Intronic RET gene variants in Down syndrome-associated Hirschsprung disease in an African population. J Pediatr Surg 47:299–302CrossRef

17.

Bolk S, Pelet A, Hofstra RM, Angrist M, Salomon R, Croaker D, Buys CH, Lyonnet S, Chakravarti A (2000) A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Proc Natl Acad Sci U S A 97:268–273CrossRef

18.

Graivier L, Sieber WK (1966) Hirschsprungs disease and mongolism. Surgery 60:458–461PubMed

19.

Friedmacher F, Puri P (2013) Hirschsprung’s disease associated with Down syndrome: a meta-analysis of incidence, functional outcomes and mortality. PediatrSurgInt 29:937–946

20.

Ieiri S, Higashi M, Teshiba R, Saeki I, Esumi G, Akiyoshi J, Nakatsuji T, Taguchi T (2009) Clinical features of Hirschsprung’s disease associated with Down syndrome: a 30-year retrospective nationwide survey in Japan. J Pediatr Surg 44:2347–2351CrossRef

21.

Puffenberger E, Kauffman E, Bolk S et al (1994) Identity-by-descent and association mapping of a recessive gene for Hirschsprung disease on human chromosome 13q22. Hum Mol Genet 3:1217–1225CrossRef

22.

Puffenberger EG (2003) Genetic heritage of the Old Order Mennonites of southeastern Pennsylvania. Am J Med Genet 121C:18–31CrossRef

23.

Li JC, Busch L, Kuhnel W (2000) Immunohistochemical study on gastroenteric nervous system in trisomy 16 mice:an animal model of Down syndrome. World JGastroenterol 6:793–799

24.

Teitelbaum DH, Qualman SJ, Caniano DA (1988) Hirschsprungs disease: Identification of risk factors for enterocolitis. Ann Surg 207:240–244CrossRef

25.

Morabito A, Lall A, Gull S, Mohee A, Bianchi A (2006) The impact of Down’s syndrome on the immediate and long-term outcomes of children with Hirschsprung’s disease. Pediatr Surg Int 22:179–181CrossRef

26.

Moore SW, Johnson GA (1998) Hirschsprungs disease: genetic and functional associations of Downs and Waardenburghs syndromes. Semin Pediatr Surg (USA) 7:156–161CrossRef

27.

Wilson-Storey WD, Scobie WG, Raeburn JA (1988) Defective white blood cell function in Hirschsprungs disease: a possible predisposing factor for enterocolitis. J R Coll Surg Edinb 33:185–188PubMed

28.

Moore SW, Sidler D, Zaahl MG (2008) The ITGB2 immunomodulatory gene (CD18), enterocolitis, and Hirschsprungs disease. J Pediatr Surg 43:1439–1444CrossRef

29.

Heuckeroth RO, Schafer KH (2016) Gene-environment interactions and the enteric nervous system: Neural plasticity and Hirschsprung disease prevention. Dev Biol 417:188–197CrossRef

30.

Boardman JP, Syrris P, Holder SE, Robertson NJ, Carter N, Lakhoo K (2001) A novel mutation in the endothelin B receptor gene in a patient with Shah-Waardenburg syndrome and Down syndrome. J Med Genet 38:646–647CrossRef

31.

Karlsen AS, Pakkenberg B (2011) Total numbers of neurons and glial cells in cortex and basal ganglia of aged brains with Down syndrome—a stereological study. CerebCortex 21:2519–2524

32.

Nakazato Y, Landing BH (1986) Reduced number of neurons in esophageal plexus ganglia in Down syndrome: additional evidence for reduced cell number as a basic feature of the disorder. Pediatr Pathol 5:55–63CrossRef

33.

Mathew A (1998) Anencephaly-associated aganglionosis. Am J Med Genet 80:518–520CrossRef

34.

Leffler A, Wedel T, Busch LC (1999) Congenital colonic hypoganglionosis in murine trisomy 16—an animal model for Down’s syndrome. Eur J Pediatr Surg 9:381–388CrossRef

35.

Becker LE, Armstrong DL, Chan F (1986) Dendritic atrophy in children with Down’s syndrome. Ann Neurol 20:520–526CrossRef

36.

Haas MA, Bell D, Slender A, Lana-Elola E, Watson-Scales S, Fisher MC et al (2013) Alterations to dendritic spine morphology, but not dendrite patterning, of cortical projection neurons in Tc1 and Ts1Rhr mouse models of Down syndrome. PLoS One 8:e78561–e78561M:24205261CrossRef

37.

Mrak RE, Griffin WS (2004) Trisomy 21 and the brain. J Neuropathol Exp Neurol 63:679–685CrossRef

38.

Chen C, Jiang P, Xue H, Peterson SE, Tran HT, McCann AE et al (2014) Role of astroglia in Down’s syndrome revealed by patient-derived human-induced pluripotent stem cells. Nat Commun 5:4430CrossRef

39.

Caviedes P, Caviedes R, Rapoport SI (2006) Altered calcium currents in cultured sensory neurons of normal and trisomy 16 mouse fetuses, an animal model for human trisomy 21 (Down syndrome). Biol Res 39:471–481CrossRef

40.

Saud K, Arriagada C, Cardenas AM, Shimahara T, Allen DD, Caviedes R, Caviedes P (2006) Neuronal dysfunction in Down syndrome: contribution of neuronal models in cell culture. J Physiol Paris 99:201–210CrossRef

41.

Christopherson KS, Ullian EM, Stokes CC, Mullowney CE, Hell JW, Agah A, Lawler J, Mosher DF, Bornstein P, Barres BA (2005) Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120:421–433CrossRef

42.

Ullian EM, Christopherson KS, Barres BA, (2004) Role for glia in synaptogenesis. Glia 47:209–216CrossRef

43.

Guizzetti M, Moore NH, Giordano G, Costa LG (2008) Modulation of neuritogenesis by astrocyte muscarinic receptors. J Biol Chem 283:31884–31897CrossRef

44.

Angrist M, Bolk S, Thiel B, Puffenberger EG, Hofstra RM, Buys CH, Cass DT, Chakravarti A (1995) Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Hum Mol Genet 4:821–830CrossRef

45.

Alves MM, Sribudiani Y, Brouwer RW, Amiel J, Antinolo G, Borrego S, Ceccherini I et al (2013) Contribution of rare and common variants determine complex diseases-Hirschsprung disease as a model. Dev Biol 382:320–329CrossRef

46.

Kapoor A, Jiang Q, Chatterjee S, Chakraborty P, Sosa MX, Berrios C, Chakravarti A (2015) Population variation in total genetic risk of Hirschsprung disease from common RET, SEMA3 and NRG1 susceptibility polymorphisms. Hum Mol Genet 24:2997–3003CrossRef

47.

de Pontual L, Pelet A, Trochet D, Jaubert F, Espinosa-Parrilla Y, Munnich A et al (2006) Mutations of the RET gene in isolated and syndromic Hirschsprung’s disease in human disclose major and modifier alleles at a single locus. J Med Genet 43:419–423CrossRef

48.

Tang CS, Tang WK, So MT, Miao XP, Leung BM, Yip BH (2011) Fine mapping of the NRG1 Hirschsprung’s disease locus. PLoSONE 6:e16181CrossRef

49.

Jiang Q, Arnold S, Heanue T, Kilambi KP, Doan B, Kapoor A, Ling AY, Sosa MX, Guy M, Jiang Q, Burzynski G, West K, Bessling S, Griseri P, Amiel J, Fernandez RM, Verheij JB, Hofstra RM, Borrego S, Lyonnet S, Ceccherini I, Gray JJ, Pachnis V, McCallion AS, Chakravarti A et al (2015) Functional loss of semaphorin 3C and/or semaphorin 3D and their epistatic interaction with ret are critical to Hirschsprung disease liability. Am J Hum Genet 96:581–596CrossRef

50.

Emison ES, McCallion AS, Kashuk CS, Bush RT, Grice E, Lin S, Portnoy ME, Cutler DJ, Green ED, Chakravarti A (2005) A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature 434:857–863CrossRef

51.

Moore SW (2006) The contribution of associated congenital anomalies in understanding Hirschsprung’s disease. Pediatr Surg Int 22:305–315CrossRef

52.

Julies MG, Moore SW, Kotze MJ, du Plessis L (2001) Novel RET mutations in Hirschsprung’s disease patients from the diverse South African population. Eur J Hum Genet 9:419–423CrossRef

53.

Zaahl MG, du Plessis L, Warnich L, Kotze MJ, Moore SW (2003) Significance of novel endothelin-B receptor gene polymorphisms in Hirschsprung’s disease: predominance of a novel variant (561C/T) in patients with co-existing Down’s syndrome. Mol Cell Probes 17:49–54CrossRef

54.

Sanchez-Mejias A, Fernandez RM, Lopez-Alonso M, Antinolo G, Borrego S (2010) New roles of EDNRB and EDN3 in the pathogenesis of Hirschsprung disease. GenetMed 12:39–43

55.

Sakai T, Wakizaka A, Nirasawa Y, Ito Y (1999) Point nucleotidic changes in both the RET proto-oncogene and the endothelin-B receptor gene in a Hirschsprung disease patient associated with Down syndrome. Tohoku J Exp Med 187:43–47CrossRef

56.

Korbel JO, Tirosh-Wagner T, Urban AE, Chen XN, Kasowski M, Dai L et al (2009) The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proc Natl Acad Sci USA 106:12031–12036CrossRef

57.

Puffenberger EG, Hosoda K, Washington SS, Nakao K, deWit D, Yanagisawa M, Chakravart A (1994) A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung’s disease. Cell 79:1256–1266CrossRef

58.

Jannot AS, Pelet A, Henrion-Caude A, Chaoui A, Masse-Morel M, Arnold S et al (2013) Chromosome 21 scan in Down syndrome reveals DSCAM as a predisposing locus in Hirschsprung disease. PLoSOne 8:e62519CrossRef

59.

Liu CP, Tang QQ, Lou JT, Luo CF, Zhou XW, Li DM, Chen F, Li X, Li JC (2010) Association analysis of the RET proto-oncogene with Hirschsprung disease in the Han Chinese population of southeastern China. Biochem Genet 48:496–503CrossRef

60.

Baumann J (2007) Down syndrome cell adhesion molecule—a common determinant of brain and heart wiring. PediatrRes 62:1

61.

de Andrade GB, Kunzelman L, Merrill MM, Fuerst PG (2014) Developmentally dynamic colocalization patterns of DSCAM with adhesion and synaptic proteins in the mouse retina. MolVis 20:1422–1433

62.

Cheng W (2018) ATP50 on human chromosome 21 as a potntial link between Hirschsprung disease and Down syndrome. poster 15 5th International symposium on development of the enteric nervous system.Boston, USA April 8–11 2018

63.

Blank M, Fuerst PG, Stevens B, Nouri N, Kirkby L, Warrier D et al (2011) The Down syndrome critical region regulates retinogeniculate refinement. JNeurosci 31:5764–5776CrossRef

64.

Moore SW, Zaahl MG (2014) Tissue specific somatic mutations and aganglionosis in Hirschsprung’s disease. J PediatrSurg 49:258–261

65.

Karousou E, Stachtea X, Moretto P, Viola M, Vigetti D, D’Angelo ML et al (2013) New insights into the pathobiology of Down syndrome–hyaluronan synthase-2 overexpression is regulated by collagen VI alpha2 chain. FEBS J 280:2418–2430CrossRef

66.

von Kaisenberg CS, Krenn V, Ludwig M, Nicolaides KH, Brand-Saberi B (1998) Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12–18 weeks and in a trisomy 16 mouse. Anat Embryol (Berl) 197:105–124CrossRef

67.

Murtomaki S, Risteli J, Risteli L, Koivisto UM, Johansson S, Liesi P (1992) Laminin and its neurite outgrowth-promoting domain in the brain in Alzheimer’s disease and Down’s syndrome patients. J Neurosci Res 32:261–273CrossRef

68.

Parikh DH, Tam PK, Van VD, Edgar D (1992) Abnormalities in the distribution of laminin and collagen type IV in Hirschsprung’s disease. Gastroenterology 102:1236–1241CrossRef

69.

Rothman TP, Goldowitz D, Gershon MD (1993) Inhibition of migration of neural crest-derived cells by the abnormal mesenchyme of the presumptive aganglionic bowel of ls/ls mice: analysis with aggregation and interspecies chimeras. Dev Biol 159:559–573CrossRef

70.

Wright TC, Orkin RW, Destrempes M, Kurnit D (1984) Increased adhesiveness of Down syndrome fetal fibroblasts in vitro. Proc Natl Acad Sci USA 81:2426–2430CrossRef

71.

Chalazonitis A, Tennyson VM, Kibbey MC, Rothman TP, Gershon MD (1997) The alpha1 subunit of laminin-1 promotes the development of neurons by interacting with LBP110 expressed by neural crest-derived cells immunoselected from the fetal mouse gut. J Neurobiol 33:118–138CrossRef

72.

Gershon MD (1999) Endothelin and the development of the enteric nervous system. Clin Exp Pharmacol Physiol 26:985–988CrossRef

73.

Meyrat BJ, Laurini RN (2003) Plasticity of the enteric nervous system in patients with intestinal neuronal dysplasia associated with Hirschsprung’s disease: a report of three patients. Pediatr Surg Int 19:715–720CrossRef

74.

Kurnit DM, Aldridge JF, Matsuoka R, Matthysse S (1985) Increased adhesiveness of trisomy 21 cells and atrioventricular canal malformations in Down syndrome: a stochastic model. AmJ Med Genet 20:385–399CrossRef

75.

Jongewaard IN, Lauer RM, Behrendt DA, Patil S, Klewer SE (2002) Beta 1 integrin activation mediates adhesive differences between trisomy 21 and non-trisomic fibroblasts on type VI collagen. Am J Med Genet 109:298–305CrossRef

76.

Nagy N, Barad C, Hotta R, Bhave S, Arciero E, Dora D, Goldstein AM (2018) Collagen 18 and agrin are secreted by neural crest cells to remodel their microenvironment and regulate their migration during enteric nervous system development. Development 145:PM:29678817CrossRef

77.

Jiang Q, Liu F, Miao C, Li Q, Zhang Z, Xiao P et al (2018) RET somatic mutations are underrecognized in Hirschsprung disease. Genet Med 20:770–777CrossRef

78.

Brosens E, MacKenzie KC, Alves MM, Hofstra RMW (2018) Do RET somatic mutations play a role in Hirschsprung disease? Genet Med. https://doi.org/10.1038/gim.2018.6 CrossRefPubMed

79.

Alves da Silva AF, Machado FB, Pavarino EC, Biselli-Perico JM, Zampieri BL, da Silva Francisco Junior R, et al (2016) Trisomy 21 alters DNA methylation in parent-of-origin-dependent and -independent manners. PLoS One 11:e0154108CrossRef

80.

Sailani MR, Santoni FA, Letourneau A, Borel C, Makrythanasis P, Hibaoui Y et al (2015) DNA-methylation patterns in trisomy 21 using cells from monozygotic twins. PLoS One 10:e0135555CrossRef

81.

Amiel J, Lyonnet S (2001) Hirschsprung disease, associated syndromes, and genetics: a review. J Med Genet 38:729–739CrossRef

82.

Moore SW, Zaahl M (2006) Immunomodulatory genes, enterocolitis and Hirschsprungs disease (HSCR). Abstract 013: British Association of Paediatric Surgeons Stockholm 19–21 July, 2006

83.

Korenberg JR, Kawashima H, Pulst SM, Ikeuchi T, Ogasawara N, Yamamoto K et al (1990) Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype. AmJ Hum Genet 47:236–246

84.

Meguid NA, Kholoussi NM, Afifi HH (2001) Evaluation of superoxide dismutase and glutathione peroxidase enzymes and their cofactors in Egyptian children with Down’s syndrome. Biol Trace Elem Res 81:21–28CrossRef

85.

Okawada M, Okazaki T, Yamataka A, Lane GJ, Miyano T (2005) Down’s syndrome and esophageal achalasia: a rare but important clinical entity. Pediatr Surg Int 21:997–1000CrossRef

86.

Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, Gao X, Neilson JR et al (2006) NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441:595–600CrossRef

87.

Epstein CJ (2006) Down’s syndrome: critical genes in a critical region. Nature 44:582–583CrossRef

88.

Moore SW (2017) Genetic impact on the treatment & management of Hirschsprung disease. J PediatrSurg 52:218–222 :.PM:28003043

89.

Burzynski GM, Nolte IM, Bronda A, Bos KK, Osinga J, Plaza Menacho I, Twigt B et al (2005) Identifying candidate Hirschsprung disease-associated RET variants. Am J Hum Genet 76:850–858CrossRef

90.

Carrasquillo MM, McCallion AS, Puffenberger EG, Kaschuk CS, No N, Chakravarti A (2002) Genome-wide association study as well as the study of mouse models help to identify the interaction between RET and EDNRB pathways in Hirschsprung disease. Nat Genet 32:237–244CrossRef

91.

Grosfeld J, Ballantine T, Csicsko J (1978) A critical evaluation of the Duhamel operation for HSCR. Arch Surg 113:454–459CrossRef

92.

Pini PA, Rossi V, Avanzini S, Mattioli G, Disma N, Jasonni V (2011) Hirschsprung’s disease: what about mortality? PediatrSurgInt 27:473–478

93.

Catto-Smith AG, Trajanovska M, Taylor RG (2006) Long-term continence in patients with Hirschsprung’s disease and Down syndrome. J Gastroenterol Hepatol 21:748–753CrossRef

94.

Caniano DA, Teitelbaum DH, Qualman SJ (1990) Management of Hirschsprungs disease in children with Trisomy 21. Am J Surg 159:402–404CrossRef

95.

Quinn FM, Surana R, Puri P (1994) The influence of trisomy 21 on outcome in children with Hirschsprung’s disease. Pediatr Surg 29:781–783CrossRef

Titel: Advances in understanding the association between Down syndrome and Hirschsprung disease (DS–HSCR)
verfasst von: S. W. Moore
Publikationsdatum: 14.09.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Pediatric Surgery International / Ausgabe 11/2018
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI: https://doi.org/10.1007/s00383-018-4344-z

Neu im Fachgebiet Pädiatrie

18.04.2024 | Spinale Muskelatrophien | Nachrichten

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Advances in understanding the association between Down syndrome and Hirschsprung disease (DS–HSCR)

Abstract

Neu im Fachgebiet Pädiatrie

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Intrakapsuläre Tonsillektomie gewinnt an Boden

Update Pädiatrie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2018

Underestimation of genital lichen sclerosus incidence in boys with phimosis: results from a systematic review

Is contralateral inguinal exploration necessary in preterm girls undergoing inguinal hernia repair during the first months of life?

Can time to healing in pediatric blunt splenic injury be predicted?

Analysis of water sports injuries admitted to a pediatric trauma center: a 13 year experience

Propranolol inhibits the activity of PI3K, AKT, and HIF-1α in infantile hemangiomas

Single center protocol driven care in 150 patients with gastroschisis 1998–2017: collaboration improves results

Neu im Fachgebiet Pädiatrie

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Intrakapsuläre Tonsillektomie gewinnt an Boden

Update Pädiatrie